Application and Rationality Evaluation of Hemostatic Drugs in the Patients with Subarachnoid Hemorrhage / 中国药师
China Pharmacist
;
(12): 279-281, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-705508
ABSTRACT
Objective:
To investigate the current use situation of hemostatics in preventing re-bleeding in the patients with sub-arachnoid hemorrhage.Methods:
The records of patients with subarachnoid hemorrhage were selected from a hospital in 2016 and the types,dosage,course and drug adverse reactions of hemostatics were recorded and evaluated according to the drug information leaflets/related guideline,drug utilization researches and adverse drug actions monitoring.Results:
Totally 81 cases with hemostatics involved 3 varieties of hemostatic drugs,the combination proportion was 16.05%,the reasonable use rate was 86.42%,the reasonable rate of administration route was 100%,the reasonable solvent rate was 98.77% and the course no more than 72 h was 88.89%. The drug uti-lization index of etamsylate injection and tranexamic acid injection was greater than one,indicating that the dosage was unreasonable. There were no adverse reactions in the 81 cases.Conclusion:
The use of hemostatics in the patients with subarachnoid hemorrhage is common,and there is still unreasonable use (such as dosage and course etc) that we should pay attention to.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacist
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS